These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 70294)
1. Cytomegalovirus-directed lymphocyte reactivity in healthy adults tested by a CMV-induced lymphocyte transformation test. Ten Napel CH; The TH; Bijker J; De Gast GC; Langenhuysen MM Clin Exp Immunol; 1977 Jul; 29(1):52-60. PubMed ID: 70294 [TBL] [Abstract][Full Text] [Related]
2. HLA-DR-restricted cytotoxicity of cytomegalovirus-infected monocytes mediated by Leu-3-positive T cells. Lindsley MD; Torpey DJ; Rinaldo CR J Immunol; 1986 Apr; 136(8):3045-51. PubMed ID: 2420881 [TBL] [Abstract][Full Text] [Related]
3. Cytomegalovirus-specific immune response and the cellular immune status of malignant lymphoma. ten Napel CH; van Egten-Bijker J; Halie MR; Langenhuysen MM; The TH J Clin Lab Immunol; 1980 Nov; 4(3):145-51. PubMed ID: 6259357 [TBL] [Abstract][Full Text] [Related]
4. Altered humoral immunity against cytomegalovirus and Epstein-Barr virus without detectable virus antigens and virus-DNA in the glomeruli of patients with IGA nephropathy in remission phase. Nagy J; Haikin H; Sarov B; Háber A; Kun L; Sarov I Acta Microbiol Immunol Hung; 1995; 42(2):179-87. PubMed ID: 7551711 [TBL] [Abstract][Full Text] [Related]
5. The cellular immune response to cell-associated and cell-free cytomegalovirus (CMV) antigens after primary CMV-infection in non-immunocompromised hosts: development and maintenance of CMV-latency and its influence on immunocompetence. Roenhorst HW; Kallenberg CG; The TH Clin Exp Immunol; 1988 Dec; 74(3):326-32. PubMed ID: 2853014 [TBL] [Abstract][Full Text] [Related]
6. Definition of human cytomegalovirus-specific target antigens recognized by cytotoxic T cells generated in vitro by using an autologous lymphocyte system. Charpentier B; Michelson S; Martin B J Immunol; 1986 Jul; 137(1):330-6. PubMed ID: 2423608 [TBL] [Abstract][Full Text] [Related]
7. Lymphocyte responses to human cytomegalovirus in different groups of patients in Britain and in adults from west Africa and the Middle East. Omisakin KA; Davidson F; Bevan DH; al Nakib W; Abdel Wahab KS; Booth JC J Med Virol; 1996 Aug; 49(4):311-8. PubMed ID: 8877764 [TBL] [Abstract][Full Text] [Related]
8. In vitro stimulation of human lymphocytes by purified cytomegalovirus. Moller-Larsen A; Andersen HK; Heron I; Sarov I Intervirology; 1975-1976; 6(4-5):249-57. PubMed ID: 186434 [TBL] [Abstract][Full Text] [Related]
9. Maintenance of cytomegalovirus (CMV) latency and host immune responses of long term renal allograft survivors. II. Secondary CMV infections associated with impaired in vitro proliferative responses to mitogens, allogeneic lymphocytes and CMV infected cells. Roenhorst HW; Beelen JM; Middeldorp JM; Schirm J; Tegzess AM; The TH Clin Exp Immunol; 1985 Jul; 61(1):72-9. PubMed ID: 2994923 [TBL] [Abstract][Full Text] [Related]
10. Maintenance of cytomegalovirus (CMV) latency and host immune responses of long term renal allograft survivors. I. Prolonged suppression of in vitro lymphocyte responses against CMV infected fibroblasts related to previous secondary CMV infection. Roenhorst HW; Middeldorp JM; Beelen JM; Schirm J; Tegzess AM; The TH Clin Exp Immunol; 1985 Mar; 59(3):709-15. PubMed ID: 2985307 [TBL] [Abstract][Full Text] [Related]
11. Persisting posttransplantation cytomegalovirus antigenemia correlates with poor lymphocyte proliferation to cytomegalovirus antigen and predicts for increased late relapse and treatment failure. Nakamura R; Battiwalla M; Solomon S; Follmann D; Chakrabarti S; Cortez K; Hensel N; Childs R; Barrett AJ Biol Blood Marrow Transplant; 2004 Jan; 10(1):49-57. PubMed ID: 14752779 [TBL] [Abstract][Full Text] [Related]